Alan B Lancz & Associates Inc. Has $771,000 Position in The Allstate Co. (NYSE:ALL)

Alan B Lancz & Associates Inc. cut its stake in The Allstate Co. (NYSE:ALL) by 7.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,000 shares of the insurance provider’s stock after selling 300 shares during the period. Allstate makes up about 0.8% of Alan B Lancz & Associates Inc.’s portfolio, making the stock its 29th biggest holding. Alan B Lancz & Associates Inc.’s holdings in Allstate were worth $771,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently modified their holdings of the stock. Pathway Financial Advisers LLC increased its position in shares of Allstate by 18,472.5% in the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after purchasing an additional 1,047,019 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Allstate by 18.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares during the period. TimesSquare Capital Management LLC acquired a new position in shares of Allstate in the 3rd quarter valued at approximately $77,819,000. Los Angeles Capital Management LLC lifted its holdings in shares of Allstate by 688.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after acquiring an additional 401,901 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Allstate by 291.9% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 356,065 shares of the insurance provider’s stock worth $67,528,000 after acquiring an additional 265,213 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Trading Up 0.7 %

NYSE ALL opened at $185.97 on Friday. The firm has a market capitalization of $49.25 billion, a PE ratio of 12.04, a price-to-earnings-growth ratio of 1.41 and a beta of 0.52. The business’s 50-day moving average price is $194.70 and its two-hundred day moving average price is $187.27. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12 month low of $153.42 and a 12 month high of $209.88.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the prior year, the business posted $0.81 earnings per share. The firm’s revenue was up 14.7% on a year-over-year basis. On average, analysts expect that The Allstate Co. will post 16.83 EPS for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a $0.92 dividend. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.98%. Allstate’s payout ratio is 23.83%.

Wall Street Analysts Forecast Growth

ALL has been the subject of several research analyst reports. Piper Sandler boosted their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. The Goldman Sachs Group boosted their price target on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a report on Friday, November 15th. BMO Capital Markets lifted their target price on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Keefe, Bruyette & Woods increased their target price on shares of Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Finally, UBS Group lifted their price target on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $218.13.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.